Sign in
4

Changes in Ownership

Kairos Pharma, LTD. Filed Acc 0001493152-25-025224

VP of Research and Development acquired 152,672 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Murali Ramachandran VP of Research and Development 2025-10-08 Grant or award +152,672 299,529 D
Loading xslF345X05/ownership.xml…